Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UltraCath Continuous Nerve block Catheter

K-Number: K162522 · 2017-03-17

Decision Date2017-03-17
Product CodeBSO
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

UltraCath Continuous Nerve block Catheter is a medical device manufactured by Teleflexmedical, Inc.. It received FDA 510(k) clearance on 2017-03-17 under approval number K162522. The device is classified under product code BSO. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UltraCath Continuous Nerve block Catheter?

UltraCath Continuous Nerve block Catheter is a medical device that received FDA 510(k) clearance on 2017-03-17. It is manufactured by Teleflexmedical, Inc.. The 510(k) number is K162522.

When was UltraCath Continuous Nerve block Catheter approved by the FDA?

UltraCath Continuous Nerve block Catheter received FDA 510(k) clearance on 2017-03-17, under approval number K162522.

What company makes UltraCath Continuous Nerve block Catheter?

UltraCath Continuous Nerve block Catheter is manufactured by Teleflexmedical, Inc..

What is the FDA product code for UltraCath Continuous Nerve block Catheter?

The FDA product code for UltraCath Continuous Nerve block Catheter is BSO.

Related Clinical Trials

Other Devices by Teleflexmedical, Inc.

View all 19 devices →

Related Devices (Code: BSO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.